HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CF PHARMTECH

15.200

-0.670-4.22%

Volume:2.77M

Turnover:42.77M

Market Cap:6.57B

PE:2.30K

High:16.050

Open:15.910

Low:15.190

Close:15.870

52wk High:48.800

52wk Low:14.820

Shares:432.00M

HK Float Shares:323.00M

Volume Ratio:0.68

T/O Rate:0.86%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.007

ROE:0.21%

ROA:-0.83%

PB:3.83

PE(LYR):2,303.03

PS:13.01

Loading ...

Overview Company News Filings

CF PharmTech publishes 2025 annual report

CF PHARMTECH (02652) Allocates HK$529,700 for Share Buyback on April 30

CF PharmTech repurchases 24,000 H shares, spending HKD 0.53 million

Bulletin Express

CF Pharmtech files HKEX next-day return disclosing buyback at HKD 22.07/share

CF PHARMTECH (02652) Spends HK$83,000 on Share Buyback on April 28

CF PharmTech repurchases 4,000 H-shares at HK$20.82 apiece, lifting treasury stock to 641,000 shares

Bulletin Express

CF PharmTech files HKEX next-day return, discloses buyback at HKD 20.82/share

CF PHARMTECH Shares Climb Over 5% on Key Clinical Milestone for In-House EBV Device

CF PharmTech executes HK$0.11 million share buy-back; treasury stock rises to 637,000 shares

Bulletin Express

CF PHARMTECH (02652) Repurchases 5,500 Shares for HK$114,000 on April 27

CF PHARMTECH (02652) Achieves Milestone with First Severe Emphysema Patient Completing Trial for Self-Developed Bronchial Valve

CF PharmTech repurchases 18,500 H-shares for HK$0.38 million; treasury stock climbs to 631,500 shares

Bulletin Express

CF PHARMTECH Repurchases Shares for HK$382,300

CF PHARMTECH Repurchases Shares Valued at HK$348,200

CF PharmTech buys back HKD 0.35 million of shares, treasury stock rises to 613,000

Bulletin Express

CF PHARMTECH (02652) Allocates HK$208,700 for Share Buyback on April 22

CF PHARMTECH Repurchases Shares Valued at HK$418,700

CF PharmTech buys back 18,500 H-shares for HK$0.42 million; treasury stock reaches 0.57 million shares

Bulletin Express

CF Pharmtech files HKEX next-day return disclosing buyback at HKD 22.63/share

CF PHARMTECH (02652) Spends HK$296,800 on Share Buyback of 13,000 Shares on April 9

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/02652/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02652","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"CF PHARMTECH","latestPrice":15.2,"timestamp":1787299688006,"preClose":15.87,"halted":0,"volume":2773800,"delay":0,"changeRate":-0.04221802142407057,"floatShares":323000000,"shares":432000000,"eps":0.0066,"marketStatus":"Market Closed","change":-0.67,"latestTime":"08-21 16:08:08","open":15.91,"high":16.05,"low":15.19,"amount":42769849,"amplitude":0.05419,"askPrice":15.3,"askSize":1800,"bidPrice":15.2,"bidSize":4600,"shortable":3,"etf":0,"ttmEps":0.006,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":15.87,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":0.6774718269660859,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02652\",,,,,undefined,":{"symbol":"02652","floatShares":323000000,"roa":"-0.83%","roe":"0.21%","lyrEps":0.0066,"volumeRatio":0.6774718269660859,"shares":432000000,"dividePrice":0,"high":16.05,"amplitude":0.05419,"preClose":15.87,"low":15.19,"week52Low":14.82,"pbRate":"3.83","psRate":"13.01","week52High":48.8,"institutionHeld":0,"latestPrice":15.2,"committee":0.4375,"eps":0.0066,"divideRate":0,"volume":2773800,"delay":0,"ttmEps":0.006,"open":15.91,"prevYearClose":35,"prevWeekClose":16.9,"prevMonthClose":19.87,"prevQuarterClose":21,"fiveDayClose":16.9,"twentyDayClose":15.76,"sixtyDayClose":19.66,"earningDate":1788105600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02652\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-30","symbol":"02652","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02652\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02652\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02652\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02652","date":"2026-08-21","current":2533.333333,"percent":0.556604,"low":-293.764894,"twenty":418.883405,"median":491.347467,"eighty":2826.107192,"high":3595.964728,"avg":1473.150348,"sd":1193.496335,"marketCap":6240837082},"quantilePoints":[{"date":"2025-10-10","current":420.512992,"twenty":-8.053739,"median":420.512992,"eighty":438.465035,"marketCap":12738371726},{"date":"2025-10-17","current":400.969089,"twenty":380.917252,"median":393.18793,"eighty":412.695431,"marketCap":12136883281},{"date":"2025-10-24","current":382.04749,"twenty":383.954109,"median":395.798507,"eighty":407.879105,"marketCap":11568353106},{"date":"2025-10-31","current":411.638127,"twenty":385.87135,"median":395.798507,"eighty":410.009732,"marketCap":12482945126},{"date":"2025-11-07","current":380.629431,"twenty":385.87135,"median":397.412529,"eighty":410.009732,"marketCap":11535394836},{"date":"2025-11-14","current":413.442652,"twenty":386.82146,"median":399.24986,"eighty":411.625005,"marketCap":12565340803},{"date":"2025-11-21","current":474.663516,"twenty":387.596392,"median":401.654037,"eighty":419.1227,"marketCap":14419243545},{"date":"2025-11-28","current":513.213561,"twenty":390.697015,"median":408.734506,"eighty":451.19497,"marketCap":15646939138},{"date":"2025-12-05","current":509.365027,"twenty":391.797785,"median":411.605323,"eighty":487.699676,"marketCap":15556303893},{"date":"2025-12-12","current":478.26383,"twenty":394.588712,"median":413.442652,"eighty":485.541496,"marketCap":14633472306},{"date":"2025-12-19","current":468.273561,"twenty":396.041553,"median":429.606948,"eighty":482.974301,"marketCap":14361566570},{"date":"2025-12-24","current":469.497744,"twenty":396.770692,"median":439.211078,"eighty":482.563912,"marketCap":14443962248},{"date":"2026-01-02","current":452.984556,"twenty":397.492287,"median":451.385447,"eighty":481.570975,"marketCap":13990786022},{"date":"2026-01-09","current":417.797013,"twenty":398.674444,"median":438.955991,"eighty":480.057858,"marketCap":12936121351},{"date":"2026-01-16","current":442.060347,"twenty":399.985866,"median":432.778937,"eighty":478.730146,"marketCap":13731858722},{"date":"2026-01-23","current":466.639698,"twenty":400.772068,"median":439.902936,"eighty":477.371374,"marketCap":14481468286},{"date":"2026-01-30","current":480.840623,"twenty":401.791027,"median":446.916666,"eighty":477.757159,"marketCap":14990389486},{"date":"2026-02-06","current":464.022312,"twenty":403.190746,"median":452.185001,"eighty":477.033593,"marketCap":14502764350},{"date":"2026-02-13","current":452.173894,"twenty":406.744138,"median":454.320794,"eighty":475.6532,"marketCap":14213623359},{"date":"2026-02-20","current":472.094804,"twenty":408.734506,"median":454.916554,"eighty":476.776403,"marketCap":14818441932},{"date":"2026-02-27","current":505.751529,"twenty":411.273773,"median":459.838493,"eighty":479.42962,"marketCap":16048983093},{"date":"2026-03-06","current":445.246344,"twenty":411.572519,"median":460.887466,"eighty":481.94993,"marketCap":14015073071},{"date":"2026-03-13","current":299.287031,"twenty":402.338985,"median":457.528006,"eighty":481.000215,"marketCap":9464083401},{"date":"2026-03-20","current":315.053976,"twenty":397.81132,"median":454.320794,"eighty":480.840623,"marketCap":9924943114},{"date":"2026-03-27","current":299.095644,"twenty":391.175665,"median":451.779671,"eighty":479.42962,"marketCap":9398246299},{"date":"2026-04-02","current":3318.248683,"twenty":389.832113,"median":451.779671,"eighty":480.872541,"marketCap":9381570423},{"date":"2026-04-10","current":3321.445916,"twenty":390.816678,"median":452.984556,"eighty":482.236241,"marketCap":9463036901},{"date":"2026-04-17","current":3317.060015,"twenty":392.419904,"median":455.282385,"eighty":483.410603,"marketCap":9454509433},{"date":"2026-04-24","current":2996.4431,"twenty":394.891161,"median":460.26919,"eighty":490.336167,"marketCap":8541149514},{"date":"2026-04-30","current":3202.871531,"twenty":396.041553,"median":462.144769,"eighty":499.979081,"marketCap":9131900891},{"date":"2026-05-08","current":3148.404437,"twenty":397.173254,"median":463.774025,"eighty":508.169798,"marketCap":9007763175},{"date":"2026-05-15","current":2973.181714,"twenty":398.099028,"median":464.50673,"eighty":512.854422,"marketCap":8528814526},{"date":"2026-05-22","current":2811.882705,"twenty":399.495195,"median":466.720409,"eighty":2921.871357,"marketCap":8047680823},{"date":"2026-05-29","current":3180.044455,"twenty":400.476536,"median":467.247998,"eighty":2926.706614,"marketCap":9133017429},{"date":"2026-06-05","current":2895.334441,"twenty":400.969089,"median":468.273561,"eighty":2926.706614,"marketCap":8327404730},{"date":"2026-06-12","current":2591.262092,"twenty":402.338985,"median":469.314298,"eighty":2919.612019,"marketCap":7447807192},{"date":"2026-06-18","current":2679.987141,"twenty":403.474666,"median":471.144686,"eighty":2910.923271,"marketCap":7719084937},{"date":"2026-06-26","current":2653.65777,"twenty":407.739322,"median":472.774581,"eighty":2903.774482,"marketCap":7608107678},{"date":"2026-07-03","current":2674.595079,"twenty":410.258066,"median":474.904398,"eighty":2905.018632,"marketCap":7673871980},{"date":"2026-07-10","current":2510.065653,"twenty":411.453021,"median":477.841604,"eighty":2898.212797,"marketCap":7192970522},{"date":"2026-07-17","current":2212.458756,"twenty":411.611884,"median":479.42962,"eighty":2892.703479,"marketCap":6362696210},{"date":"2026-07-24","current":2249.530522,"twenty":411.787912,"median":481.475073,"eighty":2888.435745,"marketCap":6470762659},{"date":"2026-07-31","current":2830.800739,"twenty":412.509722,"median":482.52515,"eighty":2884.270453,"marketCap":8158252159},{"date":"2026-08-07","current":2582.169982,"twenty":413.490204,"median":483.399827,"eighty":2872.355071,"marketCap":7456157987},{"date":"2026-08-14","current":2399.972298,"twenty":415.255724,"median":487.118208,"eighty":2848.370255,"marketCap":6938825440},{"date":"2026-08-21","current":2153.795127,"twenty":418.883405,"median":491.347467,"eighty":2826.107192,"marketCap":6240837082}],"updateTime":1787477576128},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02652\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631632291","title":"CF PharmTech publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631632291","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631632291?lang=en_us&edition=fundamental","pubTime":"2026-04-30 20:31","pubTimestamp":1777552286,"startTime":"0","endTime":"0","summary":"CF PharmTech annual report for year ended Dec. 31, 2025 flagged transition from China-focused inhaled formulations business toward global inhalation delivery platform strategy.Performance weakened as CF017 faced price pressure under VBP renewal, slower procurement execution, softer respiratory infection demand, and disruption from sales network restructuring.Product mix shifted as CF018 scaled up following reimbursement inclusion, supporting effort to reduce reliance on CF017.Overseas business moved into initial delivery stage, generating overseas revenue above RMB 10 million in 2025; cumulative overseas orders surpassed 16 million units.Pipeline advanced with IND acceptance for ICF001 in March 2026 and ICF004 in February 2026, supporting push into innovative inhaled therapies.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informatio","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL31yJkg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198849632","title":"CF PHARMTECH (02652) Allocates HK$529,700 for Share Buyback on April 30","url":"https://stock-news.laohu8.com/highlight/detail?id=1198849632","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198849632?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:10","pubTimestamp":1777543842,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 30, the company repurchased 24,000 of its shares at a cost of HK$529,700. The price per share ranged from HK$21.86 to HK$22.26.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199879514","title":"CF PharmTech repurchases 24,000 H shares, spending HKD 0.53 million","url":"https://stock-news.laohu8.com/highlight/detail?id=1199879514","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199879514?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:04","pubTimestamp":1777543476,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (02652.HK) bought back 24,000 H-shares on the Hong Kong Stock Exchange on 30 April 2026. The repurchase was executed at prices ranging from HKD 21.86 to HKD 22.26 per share,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631824826","title":"CF Pharmtech files HKEX next-day return disclosing buyback at HKD 22.07/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2631824826","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631824826?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:00","pubTimestamp":1777543202,"startTime":"0","endTime":"0","summary":"CF PharmTech reported repurchase of 24,000 H shares on Exchange on April 30, 2026.Buyback price range HKD 21.86 to HKD 22.26 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL54r2lt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192575019","title":"CF PHARMTECH (02652) Spends HK$83,000 on Share Buyback on April 28","url":"https://stock-news.laohu8.com/highlight/detail?id=1192575019","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192575019?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:27","pubTimestamp":1777379261,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that it repurchased 4,000 of its shares on April 28, 2026, at a total cost of HK$83,000.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106138707","title":"CF PharmTech repurchases 4,000 H-shares at HK$20.82 apiece, lifting treasury stock to 641,000 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1106138707","media":"Bulletin Express","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106138707?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:23","pubTimestamp":1777379032,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. filed a Next Day Disclosure Return on 28 April 2026, confirming a minor share buyback executed the same day on the Hong Kong Stock Exchange. • Transaction details: 4,000 ordinary...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630304357","title":"CF PharmTech files HKEX next-day return, discloses buyback at HKD 20.82/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2630304357","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630304357?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:21","pubTimestamp":1777378882,"startTime":"0","endTime":"0","summary":"CF PharmTech repurchased 4,000 H shares on April 28.Buyback price range was HKD 20.7 to HKD 21.04 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 28, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDLGQZvc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129431759","title":"CF PHARMTECH Shares Climb Over 5% on Key Clinical Milestone for In-House EBV Device","url":"https://stock-news.laohu8.com/highlight/detail?id=1129431759","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129431759?lang=en_us&edition=fundamental","pubTime":"2026-04-28 15:40","pubTimestamp":1777362039,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) rose more than 5%. At the time of writing, the stock was up 3.34%, trading at HK$21.64 with a turnover of HK$10.7456 million. On the news front, on April 27, CF PHARMTECH...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK4585","BK4588","BK1191","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113173013","title":"CF PharmTech executes HK$0.11 million share buy-back; treasury stock rises to 637,000 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1113173013","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113173013?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:23","pubTimestamp":1777285432,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. disclosed a repurchase of 5,500 H-shares on 27 April 2026, according to its Next Day Disclosure Return filed with the Hong Kong Stock Exchange on the same date. The shares were...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151288999","title":"CF PHARMTECH (02652) Repurchases 5,500 Shares for HK$114,000 on April 27","url":"https://stock-news.laohu8.com/highlight/detail?id=1151288999","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151288999?lang=en_us&edition=fundamental","pubTime":"2026-04-27 18:18","pubTimestamp":1777285136,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 27, 2026, the company repurchased 5,500 of its own shares at a total cost of HK$114,000.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197030790","title":"CF PHARMTECH (02652) Achieves Milestone with First Severe Emphysema Patient Completing Trial for Self-Developed Bronchial Valve","url":"https://stock-news.laohu8.com/highlight/detail?id=1197030790","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197030790?lang=en_us&edition=fundamental","pubTime":"2026-04-27 11:20","pubTimestamp":1777260037,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced on April 27, 2026, a key clinical advancement in the field of respiratory interventional medical device treatment. The first patient treated with its independently...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199558495","title":"CF PharmTech repurchases 18,500 H-shares for HK$0.38 million; treasury stock climbs to 631,500 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1199558495","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199558495?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:23","pubTimestamp":1777040618,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (H-share) disclosed a Next Day Return confirming the on-market repurchase of 18,500 ordinary shares on 24 April 2026. The buyback was executed at prices ranging from HK$20.54 to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166048292","title":"CF PHARMTECH Repurchases Shares for HK$382,300","url":"https://stock-news.laohu8.com/highlight/detail?id=1166048292","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166048292?lang=en_us&edition=fundamental","pubTime":"2026-04-24 22:08","pubTimestamp":1777039712,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 24, 2026, the company repurchased 18,500 shares at a total cost of HK$382,300.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160206791","title":"CF PHARMTECH Repurchases Shares Valued at HK$348,200","url":"https://stock-news.laohu8.com/highlight/detail?id=1160206791","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160206791?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:27","pubTimestamp":1776950821,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 23, 2026, the company repurchased 16,500 of its own shares at a total cost of HK$348,200. The repurchase price per share ranged between HK$20.9 and HK$21.34.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158174705","title":"CF PharmTech buys back HKD 0.35 million of shares, treasury stock rises to 613,000","url":"https://stock-news.laohu8.com/highlight/detail?id=1158174705","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158174705?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:23","pubTimestamp":1776950636,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. disclosed a share repurchase on 23 April 2026, executing its mandate approved on 16 December 2025. Key transaction details   • Shares repurchased: 16,500 ordinary H-shares,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199159525","title":"CF PHARMTECH (02652) Allocates HK$208,700 for Share Buyback on April 22","url":"https://stock-news.laohu8.com/highlight/detail?id=1199159525","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199159525?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:08","pubTimestamp":1776856133,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 22, 2026, the company repurchased 9,500 of its shares at a cost of HK$208,700. The price per share ranged between HK$21.88 and HK$22.10.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196574474","title":"CF PHARMTECH Repurchases Shares Valued at HK$418,700","url":"https://stock-news.laohu8.com/highlight/detail?id=1196574474","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196574474?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:25","pubTimestamp":1776695107,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 20, 2026, the company repurchased 18,500 shares at a cost of HK$418,700. The repurchase price ranged from HK$22.48 to HK$22.86 per share.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114187900","title":"CF PharmTech buys back 18,500 H-shares for HK$0.42 million; treasury stock reaches 0.57 million shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1114187900","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114187900?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:23","pubTimestamp":1776695034,"startTime":"0","endTime":"0","summary":"CF PharmTech, Inc. (H-share) reported the repurchase of 18,500 shares on 20 April 2026 under its existing mandate approved on 16 December 2025. The on-exchange purchases were executed within a price...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628729257","title":"CF Pharmtech files HKEX next-day return disclosing buyback at HKD 22.63/share","url":"https://stock-news.laohu8.com/highlight/detail?id=2628729257","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628729257?lang=en_us&edition=fundamental","pubTime":"2026-04-20 22:18","pubTimestamp":1776694692,"startTime":"0","endTime":"0","summary":"CF PharmTech reported repurchase of 18,500 H shares on April 20.Buyback price ranged from HKD 22.48 to HKD 22.86 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CF Pharmtech Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 20, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL4N9sPl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132065643","title":"CF PHARMTECH (02652) Spends HK$296,800 on Share Buyback of 13,000 Shares on April 9","url":"https://stock-news.laohu8.com/highlight/detail?id=1132065643","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132065643?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:58","pubTimestamp":1775732304,"startTime":"0","endTime":"0","summary":"CF PHARMTECH (02652) announced that on April 9, 2026, the company repurchased 13,000 shares at a total cost of HK$296,800. The repurchase price per share ranged from HK$22.56 to HK$23.00.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","02652"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":153,"code":"91000000","status":"200"}]}}